Global 3D cell culture market would reach a valuation of $2,768.8 million by 2026, according to the latest research available at Market Study Report, report provides detailed segmentation of the 3D cell culture market based on product type, by Application, by End-User and region.
 

3D cell culture can be described as an artificial environment that permits biological cells to interact or grow with its surroundings in three dimensions. This particular kind of cell culture is commonly utilized in drug discovery and tissue engineering; primarily because of its ability to provide prognostic information for in vivo tests and physiologically relevant statistics.
 

3D cell cultures boast of longer lifespans and higher stability as compared to two-dimensional cell cultures, making them ideal for long-term medical studies and assessment of a drug’s long-term effects on cells. 3D cell cultures are grown in bioreactors or cell colonies. Research estimates that 3D cells function similar to natural cells, owing to which they find applications in oncology research.
 

Growing occurrence of cancer cases and the rising need for affordable and effective treatment options would be prominent growth drivers for the 3D cell culture market. In 2015, the World Health Organization estimated that approximately 8.8 million people across the world died due to cancer.
 

Moreover, increasing investment in healthcare, optimized 3D assays development, growing R&D budgets, as well as other associated research activities would further drive 3D cell culture market growth.
 

Primarily used for testing the efficacies of novel drugs, 3D cell cultures could further be used to treat chronic diseases such as cardiovascular disease, cancer, and neurological ailments, propelling 3D cell culture implementation in pharmaceutical and biotechnology industries.
 

The 3D cell culture market is segmented on the basis of application, product types, geography, and end users. The applications segment is further divided into stem cell research, drug discovery, regenerative medicine, and cancer research. Back in 2017, cancer research accounted for the largest share of the 3D cell culture market.
 

The product landscape of the market is fragmented into bioreactors, scaffold-based platforms, microchips, gels, and services. The scaffold-based platform segment in further divided into Scaffold free platforms, Microporous scaffolds, Macro-Porous scaffolds, Solid scaffolds, and Nanoporous scaffolds. In 2017, scaffold-based culture was estimated to account for the largest industry share. Availability of a significant number of products that are based on 3D cell culture that is structure maintained is responsible for the estimated market share of the subsegment.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1695108/
 

On end-user basis, the global 3D cell culture business space is divided into pharmaceutical & biotechnology companies, academic institutes, as well as contract research laboratories. The pharmaceutical & biotechnology subsegment dominated the industry back in 2017 as the penetration of the system increased in drug discovery procedures.
 

Prominent 3D cell culture industry players include Advanced Biomatrix, 3D Biotek, Becton, Corning Incorporated, Dickinson Company (BD), Thermo Fisher Scientific Inc., Global Cell Solutions Inc., VWR Corporation, Lonza Group Ltd., Nanofiber solutions, Tecan Trading AG, and Synthecon Incorporated among others.
 

The research report provides an exhaustive 3D cell culture market analysis, enlisting its drivers, restraints, and opportunities, along with present market scenario and future trends. A brief overview of key industry trends, competitive ranking analysis, Porter's five forces, PEST analysis, ecosystem analysis, and value chain insights have also been included in the report.